Document text
Principal Investigator: JOHN P. KIRWAN
Organization: LSU PENNINGTON BIOMEDICAL RESEARCH CTR
Fiscal Year: 2024
Award: $479,565
Funding agency: National Institute of General Medical Sciences
The LA CaTS Center Administrative Core has been set up to promote, support, and continually evolve the governance and administrative structure of the Center, to effectively facilitate the necessary leadership, tools and processes required to integrate and align the Cores of the Center and accomplish the mission of building research infrastructure to address health outcomes in Louisiana. The leadership of the Administrative Core is comprised of the LA CaTS Center Principal Investigator (Pennington Biomedical Research Center) and two Program Co-Directors (LSUH-NO and Tulane University Health Sciences Center), along with support and management staff at the three administrative offices. The Administrative Core coordinates and streamlines business and management functions across the network institutions with the goal of reducing barriers, obstacles, and helping to bridge research gaps. The Core will work to maintain and further develop the culture of trust established between the partners over the past two funding cycles; one that has been particularly conducive to fostering high levels of collaboration between investigators and institutions both within and outside the state. The Core's activities will also ensure effective two-way interaction with stakeholders and close collaboration with our community partners. For the 3rd funding cycle, the Administrative Core will work with the Steering Committee and Operations Committee to act on and provide resources to support and bring to fruition the scientific opportunities identified in the Center's strategic plan. These opportunities include but are not limited to 1) facilitating “team science” and clinical trial growth; 2) strategic faculty recruitment among LA CaTS Center institutions; 3) increasing community based participatory research; and 4) promoting precision medicine and nutrition initiatives. Importantly, the Center has secured substantial resources and responsibilities across a variety of public health priorities and will continue to devote efforts to monitoring, reporting, and building on research per NIH priorities. The Administrative Core will coordinate and offer the resources, activities and initiatives that will support investigators in their goal to accomplish the overall LA CaTS Center theme “from barriers to breakthroughs: innovative approaches to chronic disease management in Louisiana.”
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Acceleration><Address><Administrative Supplement><Advisory Committees><Applications Grants><Award><Biomedical Research><Black><Black race><Businesses><COBRE><COVID testing><COVID-19><COVID-19 testing><COVID-19 therapeutics><COVID-19 vaccination><COVID-19 virus><COVID19 testing><COVID19 virus><CV-19><Cats><Cats Mammals><Center for Translational Science Activities><Center of Biomedical Research Excellence><Centers of Research Excellence><Charge><Clinical Research><Clinical Sciences><Clinical Study><Clinical Trials><Clinical Trials Unit><CoV-2><CoV2><Collaborations><Communication><Communities><Coronavirus Infectious Disease 2019><Creativeness><Diglycolaldehyde><Domestic Cats><Elements><Ensure><Environment><Equity><Faculty><Faculty Recruitment><Feline Species><Felis catus><Felis domestica><Felis domesticus><Felis sylvestris catus><Female Health><Fostering><Funding><Generalized Growth><Goals><Grant Proposals><Growth><Health><Home><Hurricane><IdA><Inosine Dialdehyde><Inox><Institution><Investigators><Leadership><Long COVID><Long COVID-19><Long coronavirus disease><Long coronavirus disease 2019><Louisiana><Mission><Monitor><NIGMS><NIH><National Institute of General Medical Sciences><National Institutes of Health><Outcome><PASC><Population><Post Acute Sequelae of COVID19><Post Acute Sequelae of SARS-CoV-2><Post Acute Sequelae of SARS-CoV2><Post Acute Sequelae of severe acute respiratory syndrome coronavirus 2><Post-Acute Sequelae of SARS-CoV-2 Infection><Pregnancy Complications><Principal Investigator><Process><RADx Underserved Populations><RADx-UP><Rapid Acceleration in Diagnostics for Underserved Populations><Rapid Acceleration of Diagnostics Underrepresented Persons><Rapid Acceleration of Diagnostics Underserved Populations><Recommendation><Reporting><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resistance><Resource Allocation><Resources><Rural Health><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 testing><SARS-CoV-2 therapeutics><SARS-CoV-2 vaccination><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 therapeutics><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Scholarship><Science><Secure><Services><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 therapeutics><Severe acute respiratory syndrome coronavirus 2 vaccination><Severe acute respiratory syndrome related corona virus 2><Strategic Planning><Structure><Task Forces><Therapeutic Intervention><Time><Tissue Growth><Training><Translational Research><Translational Research Enterprise><Translational Science><Trust><Underserved Population><United States National Institutes of Health><Universities><Vaccine Clinical Trial><Viral Genome><Vulnerable Populations><Women's Health><Work><Wuhan coronavirus><adverse sequelae of COVID><adverse sequelae of COVID-19><adverse sequelae of coronavirus disease><adverse sequelae of coronavirus disease 2019><advisory team><chronic COVID><chronic COVID-19><chronic COVID-19 sequelae><chronic novel coronavirus disease 2019><cohort><community based participatory research><community engagement><community led research><community participatory research><community partnered participatory research><community partners><community-based partners><complications during pregnancy><coronavirus disease 2019><coronavirus disease 2019 testing><coronavirus disease 2019 therapeutics><coronavirus disease 2019 vaccination><coronavirus disease 2019 virus><coronavirus disease testing><coronavirus disease-19><coronavirus disease-19 virus><coronavirus infectious disease-19><coronavirus testing><creativity><design><designing><disparity in health><diversity, equity, and inclusiveness><engagement with communities><equity, diversity, and inclusion><genome analysis><genome sequencing><hCoV19><health disparity><homes><improved><intervention therapy><long haul COVID><long haul COVID-19><long haul coronavirus disease><long haul coronavirus disease 2019><long haul sequelae of COVID-19><long haul sequelae of coronavirus disease 2019><long-hauler COVID><long-hauler COVID-19><long-hauler coronavirus disease 2019><long-hauler syndrome><long-term COVID><long-term COVID-19><long-term coronavirus disease><long-term coronavirus disease 2019><long-term sequelae of COVID-19><long-term sequelae of SARS-CoV-2><long-term sequelae of coronavirus disease 2019><long-term sequelae of severe acute respiratory syndrome coronavirus 2><longterm COVID><longterm COVID-19><longterm coronavirus disease><longterm coronavirus disease 2019><multidisciplinary><nCoV2><novel><ontogeny><operation><operations><participatory action research><patient population><persistent COVID-19><post COVID syndrome><post COVID-19 sequelae><post COVID-19 syndrome><post acute COVID syndrome><post acute COVID-19><post acute COVID-19 syndrome><post acute SARS-CoV-2><post acute coronavirus disease 2019><post acute coronavirus disease 2019 syndrome><post acute coronavirus disease syndrome><post acute sequelae following COVID-19><post acute severe acute respiratory syndrome coronavirus 2><post coronavirus disease 2019 syndrome><post coronavirus disease syndrome><post-acute phases of COVID-19><post-acute sequelae following SARS-CoV-2 infection><post-acute sequelae of COVID-19><post-acute sequelae of acute COVID infection><post-acute sequelae of coronavirus disease 2019><precision medicine><precision nutrition><precision-based medicine><pregnancy-related complications><programs><prolonged COVID-19 symptoms><recruit teachers><resilience><resilient><resistant><severe acute respiratory syndrome coronavirus 2 testing><success><teacher recruitment><telehealth><testing for COVID><testing of COVID><therapeutic vaccine><therapeutics against COVID-19><therapeutics against SARS-CoV-2><therapeutics against SARS-coronavirus-2><therapeutics against Severe acute respiratory syndrome coronavirus 2><therapeutics against coronavirus disease 2019><therapeutics for novel coronavirus><tool><translation research><translation research enterprise><translational investigation><translational research center><translational research program><translational sciences center><treatment vaccines><tropical cyclone><under served group><under served individual><under served people><under served population><underserved group><underserved individual><underserved people><vaccinate against COVID-19><vaccinate against SARS-CoV-2><vaccinate against coronavirus disease 2019><vaccinate against severe acute respiratory syndrome coronavirus 2><vaccination against COVID-19><vaccination against SARS-CoV-2><vaccination against Severe acute respiratory syndrome coronavirus 2><vaccination against coronavirus disease 2019><vaccine for the treatment><vaccine for treatment><vaping><virus genome><vulnerable group><vulnerable individual><vulnerable people>